Dr Gong Chen is Chief Surgeon and Vice Director in the Department of Colorectal Surgery at Sun Yat-sen University Cancer Center in China. He is Vice General Secretary of the Chinese Society of Clinical Oncology and Director for the colorectal branch of the Guangdong Anticancer Association. He was a member of the Colorectal Track of the Committee of Scientific Program for ASCO from 2015 to 2017. Dr Chen was also Past Director of the CSCO (Chinese Society of Clinical Oncology) Young Committee. He is a member of Beijing CSCO Funding of Clinical Study and a member of the panel for the Expert Committee of GIST, GI NETs and Colorectal Cancer of CSCO. In addition, he is member of the Standing Committee of the Colorectal Surgeon Branch for the Chinese Association of Doctors, and a member of ESMO and ASCO. Dr Chen is Editor of the Chinese version of Colorectal Cancer, Annals of Oncology and for the Chinese version of New England Journal of Medicine. He was a Visiting Scholar at Adelaide University Queen Elizabeth Hospital in Australia. His clinical interests are focused on surgical and comprehensive treatment for colorectal cancer, particularly conversion therapy for CRCLM, TNT for low-lying rectal cancer, CRS+HIPEC for peritoneal carcinomatosis and neoadjuvant immunotherapy for MSI-H colorectal cancer. He has been a co-investigator for several international multicentre randomised clinical trials, including MASCOT, AVANT, LanGIST, GRID, and ASCOLT. Dr Chen has been first author or corresponding author for more than 30 publications in international and Chinese medical journals.